glp 1 drugs heart failure Potential Mechanisms of the Protective Effects of the Cardiometabolic Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in GLP-1 Agonists in Cardiovascular Diseases:
Description
Here we highlight data informing the safety, efficacy, and potential utility of new and emerging glucagon-like peptide-1 medicines
Maintaining a healthy weight
Type 2 diabetes: principles of pathogenesis and therapy
Women may have a lower risk for thyroid cancer with GLP-1 use
However, it is now clear that the portfolio of GLP-1 drugs will remain in shortage for some amount of time and at Hims & Hers, we believe any amount of time is too long to wait for the care you deserve and the treatments you need
